SASH1 and non-small cell lung carcinoma: Evaluation of all NSCLC cases in the cohort indicated there was a significant difference in survival based on SASH1 expression, with high SASH1 showing improved survival (Fig. 1E; HR (95% CI): 1.74 (1.49–2.06), p = 6.3 × 10–11 for low SASH1 versus high SASH1, log-rank p < 0.0001)).